COMPOUND FOR THE REDUCTION OF WHITE ADIPOSE TISSUE AND THE TREATMENT OF OVERWEIGHT AND OBESITY

Patent number:

WO22123103

No items found.

The present invention relates to beta -resorcylic acid for use in reducing the amount of white adipose tissue. The inventors have discovered that beta -resorcylic acid causes a selective reduction of white adipose tissue without affecting skeletal muscle mass. The present invention thereby allows the therapeutic use of beta -resorcylic acid in preventing the accumulation of white adipose tissue or in reducing white adipose tissue. The present invention also relates to a pharmaceutical composition, to the non-therapeutic use of beta -resorcylic acid, and to a nutraceutical composition or functional food, dietary product or nutritional supplement.

Countries:

Spain

Regions:

Andalusia

Centers:

UNIVERSIDAD DE GRANADA

Other entities:

Sectors:

Health

Subsectors:

Biotechnology, Pharmaceuticals

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Preventive effect on hepatic steatosis (NASH) and appearance of non-alcoholic fatty liver characteristics. - Reduction of TAB without affecting the content of muscle mass. - Effect against overweight and/or obesity.

Comments

Other related patents

Health

NEW THERAPEUTIC PATHWAY FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES

Countries

Spain

Health

THERAPEUTIC TREATMENT AGAINST GLIOBLASTOMA CANCER

Countries

Spain

Health

ERGONOMIC HANDLE AND SYSTEM FOR ENDOSCOPIC OR LAPAROSCOPIC SURGERY INSTRUMENT

Countries

Spain

Get back to patents directory